⌘K

Login Start Free

Home/Filings/4/0001185185-16-004707

4//SEC Filing

Entia Biosciences, Inc. 4

Accession 0001185185-16-004707

CIK 0001408299operating

View on SEC.gov Company Profile

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:56 PM ET

Size

7.5 KB

Accession

0001185185-16-004707

Insider Transaction Report

Form 4

Period: 2016-05-20

Entia Biosciences, Inc.ERGO

DirectorPresident, CEO

Transactions

Purchase
Warrant
2016-05-20$0.13/sh+25,000$3,125→ 25,000 total
Exercise: $0.13From: 2016-05-20Exp: 2019-05-20→ Common Stock (25,000 underlying)
Purchase
8% Conv Debenture
2016-05-20$0.10/sh→ 250,000 total
Exercise: $0.10From: 2016-05-20Exp: 2019-05-20→ Common Stock (250,000 underlying)

Documents

1 file

4
form4-johnson052416.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Entia Biosciences, Inc.

CIK 0001408299

Entity typeoperating

IncorporatedNV

Related Parties

1

filerCIK 0001408299

Filing Metadata

Form type: 4
Filed: May 23, 8:00 PM ET
Accepted: May 24, 4:56 PM ET
Size: 7.5 KB

View on SEC.gov